Mark W. Albers, MD, PhD - Neurodegeneration and the olfactory system in Alzheimer's and other neurodegenerative diseases.

  • Lab Phone: 617-643-0680
  • Neurology Access Center: 1-855-644-6387

Research Investigator Profile

Mark Albers, MD, PhD

Mark W. Albers, MD, PhD

  • Assistant Professor of Neurology,
    Harvard Medical School
  • Assistant in Neurology,
    Department of Neurology

 

 

 

Research Description

The goal of the research in the Albers lab is to elucidate the pathogenic actions and physiological functions of genes implicated in neurodegenerative disease. Our principal hypothesis is that these genes confer vulnerability to neurons by disrupting the integrity of neurons and neural circuits. The questions addressed by these studies intersect with fundamental questions in neuroscience, including how are connections in the nervous system formed, how are these connections modified by experience, and how is the communication across these connections disrupted by disease mechanisms. We address these issues in the peripheral olfactory neural circuit of the mouse and human, a circuit that is evolutionarily conserved. The mouse circuit is genetically tractable, and the human circuit is vulnerable to neurodegenerative disease. We combine novel mouse models that express pathogenic and normal isoforms of the human amyloid precursor protein solely in  a subset of olfactory neurons with multiphoton in vivo imaging, fluorescence activated cell sorting, deep sequencing, and other basic techniques of investigation. Examination of these lines has revealed miswiring of the olfactory neural circuit and profound changes in gene expression in neurons not expressing the disease gene, associated with accelerated neuronal turnover in vivo. A second focus of the laboratory is to elucidate the physiological function of these genes by generating and examining cell-specific knockouts of the gene family in specific classes of neurons in this circuit. We believe that some of the insights revealed in these investigations will provide clues to understanding the actions of these disease genes in other vulnerable, plastic circuits in the brain, such as the entorhinal cortex and the hippocampus.  Read more.

Research interests Early pathologic events of neurodegeneration
Research techniques fMRI, transgenic models, tetracycline-regulated transcription
Diseases studied Alzheimer's disease and other neurodegenerative diseases
NCBI PubMed link NCBI PubMed Publications
E-mail address albers.mark@mgh.harvard.edu
Lab mailing address MassGeneral Institute for Neurodegenerative Disease
114 16th Street
Charlestown, MA 02129
Lab website Albers Laboratory
Clinical Profile Mark W. Albers, MD, PhD
Clinical interests Alzheimer’s disease, Parkinson’s disease
Clinical mailing address

Massachusetts General Hospital
Neurology, Suite 835
Wang Ambulatory Care Center
55 Fruit Street
Boston, MA 02114 USA

 Clinical website address

Memory Disorders Unit